Print Page | Close Window

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Haemonetics to Present at 37th Annual J.P. Morgan Healthcare Conference

BRAINTREE, Mass., Dec. 20, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019 at 3:30pm Pacific time / 6:30pm Eastern time.

HAE logo April 2016.

The public may access Mr. Simon's presentation live via webcast at: https://jpmorgan.metameetings.net/events/healthcare19/sessions/23877-haemonetics-corporation/webcast

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.

INVESTOR CONTACTS:

MEDIA CONTACT:

Gerry Gould, VP-Investor Relations

Carla Burigatto, VP-Communications

(781) 356-9402

(781) 348-7263

gerry.gould@haemonetics.com  

carla.burigatto@haemonetics.com



Olga Vlasova, Sr. Mgr.-Investor Relations


(781) 356-9763


olga.vlasova@haemonetics.com  


 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-37th-annual-jp-morgan-healthcare-conference-300769142.html

SOURCE Haemonetics Corporation